Ophthalmology, Retina Specialist · Deerfield Beach, FL
NPI
1801004932
Since 2007
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
9
Medicare group memberships
Hospitals
1
Hospital affiliations
2001 W Sample Rd Ste 320
Deerfield Beach, FL, 33064
Phone (561) 322-3588
Groups this clinician bills Medicare through
Medicare paid, 2024
$495K
5,344 services
Medicare patients, 2024
304
Average age 79
Drug cost, 2024
$1.9M
1,667 prescriptions
Company payments, 2025
$689
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Drew P Bawcombe was code J2777 (injection, faricimab-svoa, 0.1 mg), 1,986 times for 14 patients. In total Drew P Bawcombe billed 5,344 services in 37 codes, and Medicare paid $495K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 1,986 | 14 | $27.48 | $55K |
| 92134 Computerized Ophthalmic Imaging | Office | 649 | 242 | $29.45 | $19K |
| 67028 Intravitreal Injection | Office | 623 | 143 | $85.10 | $53K |
| J0178 Injection, aflibercept, 1 mg | Office | 286 | 35 | $659.26 | $189K |
| 92014 Ophthalmological E&M | Office | 261 | 171 | $88.79 | $23K |
| J7999 Compounded drug, not otherwise classified | Office | 197 | 67 | $64.58 | $13K |
| 92250 Angiography | Office | 164 | 129 | $26.21 | $4,299 |
| 76512 Ultrasound - Nonspecific | Office | 111 | 86 | $35.57 | $3,949 |
| 92235 Angiography | Office | 104 | 91 | $122.88 | $13K |
| J3490 Unclassified drugs | Office | 82 | 25 | $60.14 | $4,931 |
| 92012 Ophthalmological E&M | Office | 77 | 59 | $66.32 | $5,106 |
| J9999 Not otherwise classified, antineoplastic drugs | Office | 53 | 30 | $66.64 | $3,532 |
| 99213 Office E&M - Established | Office | 36 | 32 | $68.82 | $2,478 |
| J9035 Injection, bevacizumab, 10 mg | Office | 26 | 24 | $57.36 | $1,491 |
| 92242 Angiography | Office | 16 | 14 | $211.17 | $3,379 |
By year: 2022 $367K for 3,313 services; 2023 $428K for 3,902 services; 2024 $495K for 5,344 services.
Medicare prescription drug claims, 2024
In 2024, the drug Drew P Bawcombe prescribed most often to Medicare patients was Eylea (Aflibercept), with 343 prescriptions and refills. In total Drew P Bawcombe wrote 1,667 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 343 | 367 | 90 | $830K |
| Latanoprost Generic | 253 | 348 | 75 | $1,167 |
| Vabysmo Faricimab-Svoa | 161 | 166 | 41 | $439K |
| Prednisolone Acetate Generic | 96 | 139 | 63 | $4,127 |
| Eylea Hd Aflibercept | 94 | 115 | 28 | $299K |
| Brimonidine Tartrate Generic | 89 | 143 | 32 | $2,365 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 76 | 146 | 32 | $938 |
| Ketorolac Tromethamine Generic | 67 | 83 | 38 | $1,753 |
| Lumigan Bimatoprost | 63 | 91 | 21 | $25K |
| Syfovre Pegcetacoplan/Pf | 62 | 70 | 13 | $149K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 52 | 55 | 28 | $2,558 |
| Dorzolamide Hcl Generic | 49 | 84 | 19 | $632 |
| Timolol Maleate Generic | 40 | 74 | 12 | $399 |
| Combigan Brimonidine Tartrate/Timolol | 37 | 54 | 14 | $12K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 35 | 62 | 11 | $7,867 |
Brand drugs: 1,155 claims; generic drugs: 512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Drew P Bawcombe $689 ($689 in general payments such as food, travel and fees) from 8 companies. The largest payer was Johnson & Johnson Surgical Vision, Inc. with $276.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.